Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandins, platelets, and schizophrenia.

J Rotrosen, A D Miller, D Mandio

    Archives of General Psychiatry
    |September 1, 1980
    PubMed
    Summary

    Prostaglandin E1 significantly reduced cyclic AMP in schizophrenic platelets, suggesting altered prostaglandin function in schizophrenia. These findings may inform novel therapeutic strategies for this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gross and cytological appearance of oral gout in a crested gecko (Correlophus ciliatus) with end-stage nephropathy.

    The Journal of small animal practice·2026
    Same author

    Four Cases of the Melanotic Variant of Malignant Nerve Sheath Tumour: a Rare, Aggressive Neoplasm in Young Dogs with a Predilection for the Spinal Cord.

    Journal of comparative pathology·2020
    Same author

    Intracerebral Astrocytoma in a Horse.

    Journal of comparative pathology·2020
    Same author

    Immunohistochemical Characterization of Immune Cell Infiltration in Feline Glioma.

    Journal of comparative pathology·2018
    Same author

    Neuroendodermal cyst in the fourth ventricle of a dog.

    Australian veterinary journal·2017
    Same author

    Surgical removal of a choroid plexus oncocytoma in an adult cat.

    The Journal of small animal practice·2017

    Area of Science:

    • Biochemistry
    • Neuroscience
    • Psychiatry

    Background:

    • Prostaglandins (PGs) play crucial roles in cellular signaling.
    • Cyclic adenosine monophosphate (cAMP) is a key second messenger involved in platelet function.
    • Alterations in prostaglandin pathways have been implicated in various neurological disorders.

    Purpose of the Study:

    • To investigate the effect of Prostaglandin E1 (PGE1) on cyclic adenosine monophosphate (cAMP) formation in platelets.
    • To assess platelet PGE1 responsiveness as a potential biomarker for schizophrenia.
    • To explore the role of prostaglandins in the etiopathology and treatment of schizophrenia.

    Main Methods:

    • Platelets were pulse-labeled with 3H-adenine.
    • PGE1-stimulated 3H-adenosine-3',5'-cyclic monophosphate (3H-cAMP) accumulation was measured.
    • Comparisons were made between platelets from schizophrenic patients and healthy controls.

    Main Results:

    • Platelets from schizophrenic subjects showed a significantly reduced accumulation of 3H-cAMP in response to PGE1 compared to controls.
    • No significant differences were observed in basal 3H-cAMP accumulation or 3H-adenine incorporation between groups.

    Conclusions:

    • Reduced PGE1-stimulated cAMP formation in platelets may indicate impaired prostaglandin receptor sensitivity or function in schizophrenia.
    • These findings suggest a potential role for PGs in the pathophysiology of schizophrenia.
    • Further research into prostaglandin modulation could offer new therapeutic avenues for schizophrenia treatment.

    Related Experiment Videos